ArticleMolecular therapy. Oncology2026

Synergistic cell-cycle repression by HDAC/EZH2 co-targeting in H3K27-altered diffuse midline glioma.

Zili Zhen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.